These findings suggest that the antidepressant effect of NAc-DBS is mediated by enhancing BDNF protein expression, which in turn activates the AKT/mTOR signaling pathway, leading to the relief of CUMS-induced depression-like behaviors and hippocampal synaptic injuries in mice. Here, BDNF is linked to depressive symptom measurement.